APO RESEARCH · REPORT
Dry Eye Drugs
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Product & engineering
Understand the product.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Selected research
Industry Growth & Trends
Global Dry Eye Drugs Industry Growth and Trends Forecast to 2032
Market perspective
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
Read the full market overview
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
Report Scope
This report provides a structured, data-driven view of the global Dry Eye Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dry Eye Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dry Eye Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dry Eye Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Dry Eye Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dry Eye Drugs Market by Company
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Dry Eye Drugs Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Dry Eye Drugs Segment by Application
Hospital
Drug Stores
Online Pharmacies
Dry Eye Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dry Eye Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Anti-inflammatory Drugs
- Other
Applications
- Hospital
- Drug Stores
- Online Pharmacies
Companies covered
- Allergan
- Novartis AG
- Bausch Health
- Santen Pharma
- Takeda
- Johnson & Johnson
- United Laboratories
- Senju Pharmaceutical
- Jianfeng Group
- Eusan GMBH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dry Eye Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Dry Eye Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Dry Eye Drugs Market by Type
- 1.3.1 Artificial Tears
- 1.3.2 Anti-inflammatory Drugs
- 1.3.3 Other
- 1.4 Global Dry Eye Drugs Market Size by Type
- 1.4.1 Global Dry Eye Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Dry Eye Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Dry Eye Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Dry Eye Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Dry Eye Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Dry Eye Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Dry Eye Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Dry Eye Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Dry Eye Drugs Industry Trends
- 2.2 Dry Eye Drugs Industry Drivers
- 2.3 Dry Eye Drugs Industry Opportunities and Challenges
- 2.4 Dry Eye Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Dry Eye Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Dry Eye Drugs Sales (2021-2026)
- 3.3 Global Top Players by Dry Eye Drugs Price (2021-2026)
- 3.4 Global Dry Eye Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dry Eye Drugs Major Company Production Sites & Headquarters
- 3.6 Global Dry Eye Drugs Company, Product Type & Application
- 3.7 Global Dry Eye Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dry Eye Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dry Eye Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Dry Eye Drugs Tier 1, Tier 2, and Tier 3
4 Dry Eye Drugs Regional Status and Outlook
- 4.1 Global Dry Eye Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Dry Eye Drugs Historic Market Size by Region
- 4.2.1 Global Dry Eye Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Dry Eye Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Dry Eye Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Dry Eye Drugs Forecasted Market Size by Region
- 4.3.1 Global Dry Eye Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Dry Eye Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Dry Eye Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dry Eye Drugs by Application
- 5.1 Dry Eye Drugs Market by Application
- 5.1.1 Hospital
- 5.1.2 Drug Stores
- 5.1.3 Online Pharmacies
- 5.2 Global Dry Eye Drugs Market Size by Application
- 5.2.1 Global Dry Eye Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Dry Eye Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Dry Eye Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Dry Eye Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Dry Eye Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Dry Eye Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Dry Eye Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Dry Eye Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Allergan
- 6.1.1 Allergan Company Information
- 6.1.2 Allergan Business Overview
- 6.1.3 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Allergan Dry Eye Drugs Product Portfolio
- 6.1.5 Allergan Recent Developments
- 6.2 Novartis AG
- 6.2.1 Novartis AG Company Information
- 6.2.2 Novartis AG Business Overview
- 6.2.3 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novartis AG Dry Eye Drugs Product Portfolio
- 6.2.5 Novartis AG Recent Developments
- 6.3 Bausch Health
- 6.3.1 Bausch Health Company Information
- 6.3.2 Bausch Health Business Overview
- 6.3.3 Bausch Health Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bausch Health Dry Eye Drugs Product Portfolio
- 6.3.5 Bausch Health Recent Developments
- 6.4 Santen Pharma
- 6.4.1 Santen Pharma Company Information
- 6.4.2 Santen Pharma Business Overview
- 6.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Santen Pharma Dry Eye Drugs Product Portfolio
- 6.4.5 Santen Pharma Recent Developments
- 6.5 Takeda
- 6.5.1 Takeda Company Information
- 6.5.2 Takeda Business Overview
- 6.5.3 Takeda Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Takeda Dry Eye Drugs Product Portfolio
- 6.5.5 Takeda Recent Developments
- 6.6 Johnson & Johnson
- 6.6.1 Johnson & Johnson Company Information
- 6.6.2 Johnson & Johnson Business Overview
- 6.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Johnson & Johnson Dry Eye Drugs Product Portfolio
- 6.6.5 Johnson & Johnson Recent Developments
- 6.7 United Laboratories
- 6.7.1 United Laboratories Company Information
- 6.7.2 United Laboratories Business Overview
- 6.7.3 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 United Laboratories Dry Eye Drugs Product Portfolio
- 6.7.5 United Laboratories Recent Developments
- 6.8 Senju Pharmaceutical
- 6.8.1 Senju Pharmaceutical Company Information
- 6.8.2 Senju Pharmaceutical Business Overview
- 6.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Senju Pharmaceutical Dry Eye Drugs Product Portfolio
- 6.8.5 Senju Pharmaceutical Recent Developments
- 6.9 Jianfeng Group
- 6.9.1 Jianfeng Group Company Information
- 6.9.2 Jianfeng Group Business Overview
- 6.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jianfeng Group Dry Eye Drugs Product Portfolio
- 6.9.5 Jianfeng Group Recent Developments
- 6.10 Eusan GMBH
- 6.10.1 Eusan GMBH Company Information
- 6.10.2 Eusan GMBH Business Overview
- 6.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Eusan GMBH Dry Eye Drugs Product Portfolio
- 6.10.5 Eusan GMBH Recent Developments
7 North America by Country
- 7.1 North America Dry Eye Drugs Sales by Country
- 7.1.1 North America Dry Eye Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Dry Eye Drugs Sales by Country (2021-2026)
- 7.1.3 North America Dry Eye Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Dry Eye Drugs Market Size by Country
- 7.2.1 North America Dry Eye Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Dry Eye Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Dry Eye Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Dry Eye Drugs Sales by Country
- 8.1.1 Europe Dry Eye Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Dry Eye Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Dry Eye Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Dry Eye Drugs Market Size by Country
- 8.2.1 Europe Dry Eye Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Dry Eye Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Dry Eye Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Dry Eye Drugs Sales by Country
- 9.1.1 Asia-Pacific Dry Eye Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Dry Eye Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Dry Eye Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Dry Eye Drugs Market Size by Country
- 9.2.1 Asia-Pacific Dry Eye Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Dry Eye Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Dry Eye Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Dry Eye Drugs Sales by Country
- 10.1.1 South America Dry Eye Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Dry Eye Drugs Sales by Country (2021-2026)
- 10.1.3 South America Dry Eye Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Dry Eye Drugs Market Size by Country
- 10.2.1 South America Dry Eye Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Dry Eye Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Dry Eye Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Dry Eye Drugs Sales by Country
- 11.1.1 Middle East and Africa Dry Eye Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Dry Eye Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Dry Eye Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Dry Eye Drugs Market Size by Country
- 11.2.1 Middle East and Africa Dry Eye Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Dry Eye Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Dry Eye Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Dry Eye Drugs Value Chain Analysis
- 12.1.1 Dry Eye Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Dry Eye Drugs Production Mode & Process
- 12.2 Dry Eye Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Dry Eye Drugs Distributors
- 12.2.3 Dry Eye Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst